P
Pantera
Large-scale actinium-225 production for targeted cancer therapy
About Pantera
PanTera is a biotechnology company dedicated to advancing cancer treatment through the development and application of radiopharmaceuticals. Our mission is to bring new hope to cancer patients by enabling the widespread use of precision therapies that target and treat tumors effectively.
At PanTera, we recognize the significant potential of radiopharmaceuticals in transforming cancer care. These innovative therapies combine radioactive isotopes with targeting molecules to deliver precise, localized radiation to cancer cells, minimizing damage to healthy tissue. By harnessing the power of radiopharmaceuticals, we aim to improve treatment outcomes and enhance the quality of life for patients.
Our focus is on developing and optimizing radiopharmaceuticals that can be used in a variety of cancer types. We work closely with researchers, clinicians, and industry partners to advance the science of radiopharmaceuticals and bring these therapies to a broader range of patients. Our team of experts is committed to overcoming the technical and logistical challenges associated with the production, distribution, and administration of radiopharmaceuticals.
PanTera's approach is grounded in a deep understanding of cancer biology and the unique properties of radiopharmaceuticals. We employ advanced technologies and rigorous scientific methods to design and test new therapies, ensuring their safety and efficacy. Our goal is to create a portfolio of radiopharmaceuticals that can be tailored to the specific needs of individual patients, providing personalized and effective treatment options.
In addition to our research and development efforts, PanTera is dedicated to educating healthcare professionals and patients about the benefits of radiopharmaceuticals. We believe that increased awareness and understanding of these therapies will lead to greater adoption and improved patient access. By collaborating with key stakeholders in the healthcare community, we aim to build a supportive ecosystem for the use of radiopharmaceuticals in cancer treatment.
PanTera is driven by a passion to make a meaningful difference in the lives of cancer patients. Our commitment to innovation, scientific excellence, and patient-centered care guides our work and inspires us to push the boundaries of what is possible in cancer treatment.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Mol, Belgium
- Employees
- 63
- Open positions
- 3
- Dealroom signal
- 92.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Oncology, Radiotherapy, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Sep 2024 | $102M | $409M | Eurazeo · PMV · Korys · Kurma Partners | ↗ |
| DEBTDebt | Sep 2024 | $37M | — | Belfius · KBC | ↗ |
Growth signals
Latest recorded traffic for Pantera is 1.6K monthly website visits, up 135.3% over the last three months. Pantera's team grew 26% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
EQT Life Sciences
Eurazeo
PMV
Korys
Kurma Partners
SFPIM
IBA Worldwide
Series B and later2 investors entered at this stage
Belfius
KBC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pantera on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pantera’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







